Macrodissection prior to closed system RT-qPCR is not necessary for estrogen receptor and HER2 concordance with IHC/FISH in breast cancer

被引:10
|
作者
Gupta, Swati [1 ]
Mani, Navin R. [1 ]
Carvajal-Hausdorf, Daniel E. [1 ,2 ]
Bossuyt, Veerle [1 ]
Ho, Kenneth [3 ]
Weidler, Jodi [4 ]
Wong, Wendy [3 ]
Rhees, Brian [3 ]
Bates, Michael [4 ]
Rimm, David L. [1 ]
机构
[1] Yale Univ, Sch Med, Dept Pathol, New Haven, CT 06510 USA
[2] Univ Desarrollo, Fac Med, Clin Alemana, Anat Patol, Santiago, Chile
[3] Cepheid, Div Oncol Res & Dev, Oncol, Sunnyvale, CA USA
[4] Cepheid, Med & Sci Affairs & Strategy, Oncol, Sunnyvale, CA USA
关键词
MESSENGER-RNA; IN-SITU; IMMUNOHISTOCHEMISTRY; CARCINOMA; TAMOXIFEN; ASSAY;
D O I
10.1038/s41374-018-0064-1
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
An on-demand, closed RT-qPCR, the GeneXpert (GX) system, has the potential to provide biomarker information in low-resourced settings and elsewhere. We used this system with a research use only version of the Breast Cancer STRAT4 cartridge that measures the mRNA expression levels of ERBB2, ESR1, PGR, and MKi67. Here we evaluated the impact of non-macrodissected (non m-d) versus macrodissected (m-d) samples using STRAT4 on formalin-fixed, paraffin-embedded (FFPE) core needle biopsies. Two cohorts were assessed: (1) 60 FFPE infiltrating ductal carcinoma (IDCA) cases and (2) 20 FFPE IDCA cases with ductal carcinoma in situ (DCIS) with a range of HER2 expression as determined by clinical immunohistochemistry and fluorescence in situ hybridization (IHC/FISH). We observed about half of the core needle biopsy area as invasive tumor in both IDCA (mean = 51.5%) and IDCA with DCIS (mean = 53.5%) cohorts, but also found the mRNA levels were independent of tumor area. We found excellent agreement of the mRNA transcript level between the paired samples, m-d versus non m-d, for ERBB2, ESR1, PGR, and MKi67 for both the IDCA and IDCA with DCIS cohorts. No significant difference (P > 0.99) was observed when we compared the mRNA transcript level between the paired samples m-d versus non m-d. In addition, we noted a significant concordance (P < 0.001) between RT-qPCR and IHC/FISH for HER2-positivity, ER-positivity, and PR-positivity, independent of specimen dissection. These data suggest that mRNA expression for ERBB2, ESR, and PGR is sufficiently low in surrounding tissue cells such that macrodissection is not required for assessment of key breast cancer mRNA markers and is independent of the amount of input tumor. This approach may be valuable in settings lacking pathology expertise or using specimen types, such as fine-needle aspirates, where it may be challenging to separate non-tumor from tumor tissue.
引用
收藏
页码:1076 / 1083
页数:8
相关论文
共 50 条
  • [31] Comparison of ESR1, PGR, HER2 and KI67 expression by central IHC and MammaTyper® RT-qPCR kit in the FinHer trial
    Wirtz, Ralph M.
    Kellokumpu-Lehtinen, Pirkko-Liisa
    Isola, Jorma
    Kataja, Vesa
    Bono, Petri
    Turpeenniemi-Hujanen, Taina
    Jyrkkio, Sirkuu
    Sitho, Harri
    Eidt, Sebastian
    Sahin, Ugur
    Joensuu, Heikki
    CANCER RESEARCH, 2015, 75
  • [32] A meta-analysis on concordance between immunohistochemistry (IHC) and fluorescence in situ hybridization (FISH) to detect HER2 gene overexpression in breast cancer
    Fatemeh Bahreini
    Ali Reza Soltanian
    Parvin Mehdipour
    Breast Cancer, 2015, 22 : 615 - 625
  • [33] A meta-analysis on concordance between immunohistochemistry (IHC) and fluorescence in situ hybridization (FISH) to detect HER2 gene overexpression in breast cancer
    Bahreini, Fatemeh
    Soltanian, Ali Reza
    Mehdipour, Parvin
    BREAST CANCER, 2015, 22 (06) : 615 - 625
  • [34] Impact of HER2 Copy Number in IHC HER2 2+/FISH Positive Breast Cancer on Outcome of Adjuvant Trastuzumab Treatment
    Borley, A.
    Mercer, T.
    Morgan, M.
    Barrett-Lee, P.
    Jasani, B.
    JOURNAL OF PATHOLOGY, 2013, 231 : 19 - 19
  • [35] HER2 testing in metastatic breast cancer-Is reflex ISH testing necessary on HER2 IHC-equivocal (2+) cases?
    Liwski, Christopher R.
    Castonguay, Mathieu C.
    Barnes, Penny J.
    Rayson, Daniel
    Bethune, Gillian C.
    ANNALS OF DIAGNOSTIC PATHOLOGY, 2022, 59
  • [36] Laser microdissection compared to whole tissue paraffin macrodissection in evaluation of HER2 receptor expression in breast cancer
    Thode, J.
    Jorgensen, M. K.
    Pedersen, C.
    Pedersen, A.
    Mygind, H.
    APMIS, 2009, 117 : 21 - 21
  • [37] Study of Concordance between RT-PCR and Immunohistochemical Testing of Hormone Receptor and HER2 Status in Breast Cancer Specimens
    Mehta, R.
    Jain, R. K.
    Sojitra, P. M.
    Gokmen-Polar, Y.
    Badve, S.
    LABORATORY INVESTIGATION, 2011, 91 : 54A - 54A
  • [38] Is there an association between estrogen receptor and Her2/neu status in breast cancer?
    Hanna, W
    Kahn, HJ
    Szalai, JP
    MODERN PATHOLOGY, 2002, 15 (01) : 36A - 36A
  • [39] Immunohistochemical double staining with estrogen receptor and HER2 on primary breast cancer
    Horiguchi, J
    Koibuchi, Y
    Iijima, K
    Yoshida, T
    Yoshida, M
    Takata, D
    Oyama, T
    Iino, Y
    Morishita, Y
    INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE, 2003, 12 (06) : 855 - 859
  • [40] Co-targeting estrogen receptor and HER2 pathways in breast cancer
    Mehta, Arjun
    Tripathy, Debu
    BREAST, 2014, 23 (01): : 2 - 9